Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (1,086 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Alcohol, Propyl; Propyl Alcohol; n-Propanol; Propanol.
Where it fits in the MeSH classification
- Broader topics
- Propanols
Research landscape
PubMed indexes 2,946 records tagged with the MeSH heading “1-Propanol” (counts retrieved 2026-10-31). 101 of them (3.4%) were published from 2020 onward, and the busiest period so far is through 1999 with 2,337 records.
Reviews account for 48 records (1.6%) and meta-analyses for 0. Randomized controlled trials number 34 (1.2%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.
Show the data
| Period | Records |
|---|---|
| through 1999 | 2,337 |
| 2000-2009 | 278 |
| 2010-2019 | 230 |
| 2020 onward | 101 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 48 | 1.6% |
| Meta-analyses | 0 | 0.0% |
| Randomized controlled trials | 34 | 1.2% |
Method: PubMed query "1-Propanol"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.
Reading the evidence in drugs and chemicals
Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Dehydratase mediated 1-propanol production in metabolically engineered Escherichia coli | 2011 | Research article Design not recorded in structured metadata | 30 | cc by PMID 22074179 · DOI · PMC3245452 |
| Metabolic engineering of the 2-ketobutyrate biosynthetic pathway for 1-propanol production in Saccharomyces cerevisiae | 2018 | Research article Design not recorded in structured metadata | 24 | cc by PMID 29523149 · DOI · PMC5844117 |
| Identification of Volatile Markers of Colorectal Cancer from Tumor Tissues Using Volatilomic Approach | 2023 | Research article Design not recorded in structured metadata | 17 | cc by PMID 37630241 · DOI · PMC10459111 |
| Engineering the hyperthermophilic archaeon Pyrococcus furiosus for 1-propanol production | 2025 | Research article Design not recorded in structured metadata | 1 | cc by PMID 40192334 · DOI · PMC12094016 |
Dehydratase mediated 1-propanol production in metabolically engineered Escherichia coli [1]
Abstract reading summary — source excerpts
- Opening excerpt
- BackgroundWith the increasing consumption of fossil fuels, the question of meeting the global energy demand is of great importance in the near future.
- Closing excerpt
- We speculate that dragging more carbon flux towards methylglyoxal by manipulating glycolytic pathway and eliminating competing pathways such as lactate generation can further enhance the production of 1-propanol.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (329 words)
BackgroundWith the increasing consumption of fossil fuels, the question of meeting the global energy demand is of great importance in the near future. As an effective solution, production of higher alcohols from renewable sources by microorganisms has been proposed to address both energy crisis and environmental concerns. Higher alcohols contain more than two carbon atoms and have better physiochemical properties than ethanol as fuel substitutes.ResultsWe designed a novel 1-propanol metabolic pathway by expanding the well-known 1,2-propanediol pathway with two more enzymatic steps catalyzed by a 1,2-propanediol dehydratase and an alcohol dehydrogenase. In order to engineer the pathway into E. coli, we evaluated the activities of eight different methylglyoxal synthases which play crucial roles in shunting carbon flux from glycolysis towards 1-propanol biosynthesis, as well as two secondary alcohol dehydrogenases of different origins that reduce both methylglyoxal and hydroxyacetone. It is evident from our results that the most active enzymes are the methylglyoxal synthase from Bacillus subtilis and the secondary alcohol dehydrogenase from Klebsiella pneumoniae, encoded by mgsA and budC respectively. With the expression of these two genes and the E. coli ydjG encoding methylglyoxal reductase, we achieved the production of 1,2-propanediol at 0.8 g/L in shake flask experiments. We then characterized the catalytic efficiency of three different diol dehydratases on 1,2-propanediol and identified the optimal one as the 1,2-propanediol dehydratase from Klebsiella oxytoca, encoded by the operon ppdABC. Co-expressing this enzyme with the above 1,2-propanediol pathway in wild type E. coli resulted in the production of 1-propanol at a titer of 0.25 g/L.ConclusionsWe have successfully established a new pathway for 1-propanol production by shunting the carbon flux from glycolysis. To our knowledge, it is the first time that this pathway has been utilized to produce 1-propanol in E. coli. The work presented here forms a basis for further improvement in production. We speculate that dragging more carbon flux towards methylglyoxal by manipulating glycolytic pathway and eliminating competing pathways such as lactate generation can further enhance the production of 1-propanol.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 22074179 · DOI · PMC3245452
Metabolic engineering of the 2-ketobutyrate biosynthetic pathway for 1-propanol production in Saccharomyces cerevisiae [2]
Abstract reading summary — source excerpts
- Opening excerpt
- BackgroundTo produce 1-propanol as a potential biofuel, metabolic engineering of microorganisms, such as E.
- Closing excerpt
- cerevisiae is necessary to harness this pathway, it is a promising candidate for the large-scale production of 1-propanol.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (206 words)
BackgroundTo produce 1-propanol as a potential biofuel, metabolic engineering of microorganisms, such as E. coli, has been studied. However, 1-propanol production using metabolically engineered Saccharomyces cerevisiae, which has an amazing ability to produce ethanol and is thus alcohol-tolerant, has infrequently been reported. Therefore, in this study, we aimed to engineer S. cerevisiae strains capable of producing 1-propanol at high levels.ResultsWe found that the activity of endogenous 2-keto acid decarboxylase and alcohol/aldehyde dehydrogenase is sufficient to convert 2-ketobutyrate (2 KB) to 500 mg/L 1-propanol in yeast. Production of 1-propanol could be increased by: (i) the construction of an artificial 2 KB biosynthetic pathway from pyruvate via citramalate (cimA); (ii) overexpression of threonine dehydratase (tdcB); (iii) enhancement of threonine biosynthesis from aspartate (thrA, thrB and thrC); and (iv) deletion of the GLY1 gene that regulates a competing pathway converting threonine to glycine. With high-density anaerobic fermentation of the engineered S. cerevisiae strain YG5C4231, we succeeded in producing 180 mg/L 1-propanol from glucose.ConclusionThese results indicate that the engineering of a citramalate-mediated pathway as a production method for 1-propanol in S. cerevisiae is effective. Although optimization of the carbon flux in S. cerevisiae is necessary to harness this pathway, it is a promising candidate for the large-scale production of 1-propanol.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29523149 · DOI · PMC5844117
Identification of Volatile Markers of Colorectal Cancer from Tumor Tissues Using Volatilomic Approach [3]
Abstract reading summary — source excerpts
- Opening excerpt
- The human body releases numerous volatile organic compounds (VOCs) through tissues and various body fluids, including breath.
- Closing excerpt
- Reliable identification of the VOCs associated with CRC is essential to guide and tune the development of advanced sensor technologies that can effectively and sensitively detect and quantify these markers.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (240 words)
The human body releases numerous volatile organic compounds (VOCs) through tissues and various body fluids, including breath. These compounds form a specific chemical profile that may be used to detect the colorectal cancer CRC-related changes in human metabolism and thereby diagnose this type of cancer. The main goal of this study was to investigate the volatile signatures formed by VOCs released from the CRC tissue. For this purpose, headspace solid-phase microextraction gas chromatography-mass spectrometry was applied. In total, 163 compounds were detected. Both cancerous and non-cancerous tissues emitted 138 common VOCs. Ten volatiles (2-butanone; dodecane; benzaldehyde; pyridine; octane; 2-pentanone; toluene; p-xylene; n-pentane; 2-methyl-2-propanol) occurred in at least 90% of both types of samples; 1-propanol in cancer tissue (86% in normal one), acetone in normal tissue (82% in cancer one). Four compounds (1-propanol, pyridine, isoprene, methyl thiolacetate) were found to have increased emissions from cancer tissue, whereas eleven showed reduced release from this type of tissue (2-butanone; 2-pentanone; 2-methyl-2-propanol; ethyl acetate; 3-methyl-1-butanol; d-limonene; tetradecane; dodecanal; tridecane; 2-ethyl-1-hexanol; cyclohexanone). The outcomes of this study provide evidence that the VOCs signature of the CRC tissue is altered by the CRC. The volatile constituents of this distinct signature can be emitted through exhalation and serve as potential biomarkers for identifying the presence of CRC. Reliable identification of the VOCs associated with CRC is essential to guide and tune the development of advanced sensor technologies that can effectively and sensitively detect and quantify these markers.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 37630241 · DOI · PMC10459111
Engineering the hyperthermophilic archaeon Pyrococcus furiosus for 1-propanol production [4]
Abstract reading summary — source excerpts
- Opening excerpt
- Society relies heavily on chemicals traditionally produced through the refinement of fossil fuels.
- Closing excerpt
- Genome-scale metabolic modeling informed the carbon and reductant flux in the system, identified potential factors limiting 1-propanol production, and revealed potential optimization targets.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (311 words)
Society relies heavily on chemicals traditionally produced through the refinement of fossil fuels. The conversion of renewable biomass to value-added chemicals by microbes, particularly hyperthermophiles (Topt ≥80°C), offers a renewable alternative to this traditional approach. Herein, we describe the engineering of the hyperthermophilic archaeon Pyrococcus furiosus, which grows optimally (Topt) at 100°C, for the conversion of sugar to 1-propanol. This was accomplished by constructing a hybrid metabolic pathway consisting of two native and seven heterologously produced enzymes to convert acetyl-CoA from carbohydrate metabolism to 1-propanol. A total of eleven foreign genes from two other organisms were utilized, one from the thermophilic bacterium Thermoanaerobacter sp. strain X514 and 10 from the thermoacidophilic archaeon Metallosphaera sedula, both of which grow optimally near 70°C. The recombinant P. furiosus strain produced 1-propanol at similar concentrations (up to ~1 mM) when incubated at 75°C to activate the gene products of Thermoanaerobacter sp. strain X514 and M. sedula and by initially incubating at 95°C for P. furiosus growth and then subsequently returning to 75°C to promote 1-propanol formation. Note that 1-propanol was not produced if the culture was grown only at 95°C. This work has the potential for future optimization through harnessing the genome-scale metabolic model of P. furiosus that was used herein to identify engineering targets to increase 1-propanol titer.IMPORTANCEAs petroleum reserves become increasingly strained, the development of renewable alternatives to traditional chemical synthesis becomes more important. In this work, a high-temperature biological system for sugar to 1-propanol conversion was demonstrated by metabolic engineering of the hyperthermophilic archaeon Pyrococcus furiosus (Topt 100°C). The engineered strain produced 1-propanol by temperature shifting from 75°C to 95°C and then back to 75°C to accommodate the temperature ranges for native and foreign proteins associated with 1-propanol biosynthesis. Genome-scale metabolic modeling informed the carbon and reductant flux in the system, identified potential factors limiting 1-propanol production, and revealed potential optimization targets.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40192334 · DOI · PMC12094016
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article Hand antiseptics: rubs versus scrubs, alcoholic solutions versus alcoholic gels [5]
- Research article The alcohols: ethanol, methanol, isopropanol, ethylene glycol [6]
- Research article The other alcohols. Methanol, ethylene glycol, and isopropanol [7]
- Research article How irritant are n-propanol and isopropanol? - A systematic review [8]
- Research article Trigeminally-mediated health effects of air pollutants: sources of inter-individual variability [9]
- Research article Isopropyl alcohol intoxication [10]
References
- Jain R, Yan Y. Dehydratase mediated 1-propanol production in metabolically engineered Escherichia coli. . 2011. PMID 22074179 · DOI · PMC3245452
- Nishimura Y, Matsui T, Ishii J, Kondo A, Kondo A. Metabolic engineering of the 2-ketobutyrate biosynthetic pathway for 1-propanol production in Saccharomyces cerevisiae. . 2018. PMID 29523149 · DOI · PMC5844117
- Mezmale L, Leja M, Lescinska AM, Pčolkins A, Kononova E, Bogdanova I, et al.. Identification of Volatile Markers of Colorectal Cancer from Tumor Tissues Using Volatilomic Approach. . 2023. PMID 37630241 · DOI · PMC10459111
- O'Quinn HC, Vailionis JL, Tanwee TNN, Holandez-Lopez KS, Bing RG, Poole FL, et al.. Engineering the hyperthermophilic archaeon Pyrococcus furiosus for 1-propanol production. . 2025. PMID 40192334 · DOI · PMC12094016
- Pietsch H. Hand antiseptics: rubs versus scrubs, alcoholic solutions versus alcoholic gels. J Hosp Infect. 2001. PMID 11759022 · DOI
- Litovitz T. The alcohols: ethanol, methanol, isopropanol, ethylene glycol. Pediatr Clin North Am. 1986. PMID 2870460 · DOI
- Burkhart KK, Kulig KW. The other alcohols. Methanol, ethylene glycol, and isopropanol. Emerg Med Clin North Am. 1990. PMID 2226295 · DOI
- Tasar R, Wiegand C, Elsner P. How irritant are n-propanol and isopropanol? - A systematic review. Contact Dermatitis. 2021. PMID 33063847 · DOI · PMC7675697
- Shusterman D. Trigeminally-mediated health effects of air pollutants: sources of inter-individual variability. Hum Exp Toxicol. 2007. PMID 17439917 · DOI
- Rich J, Scheife RT, Katz N, Caplan LR. Isopropyl alcohol intoxication. Arch Neurol. 1990. PMID 2178594 · DOI
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-31.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.